NCT00704223View on ClinicalTrials.gov

Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes

CompletedOBSERVATIONAL

Enrollment

619

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart

Start dose and frequency to prescribed by the physician as a result of a normal clinical evaluation

Trial Locations (1)

1140

Vienna

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY